Developing a method to derive alcohol-attributable fractions for HIV/AIDS mortality based on alcohol's impact on adherence to antiretroviral medication

Population Health Metrics

Volumn 9, Issue , 2011, Pages

  Gmel, Gerrit ^a,b   Shield, Kevin D ^a,c   Rehm, Jürgen ^a,c,d  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b EPFL   (Switzerland)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALCOHOL; ANTIMICROBIAL ACTIVITY; DISEASE INCIDENCE; DISEASE TREATMENT; DRINKING; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; MORTALITY; UNCERTAINTY ANALYSIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICA; AGE; ALCOHOL CONSUMPTION; ARTICLE; CALCULATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT REFUSAL; UNCERTAINTY; VARIANCE;

AFRICA; MIDDLE EAST;

EID: 79851514017     PISSN: None     EISSN: 14787954     Source Type: Journal    
DOI: 10.1186/1478-7954-9-5     Document Type: Article

References (34)

1. World Health Organization Global Health Risks. Mortality and burden of disease attributable to selected major risks 2009, Geneva, Switzerland, World Health Organization.
2. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009, 373:2223-22233. 10.1016/S0140-6736(09)60746-7, 19560604.
3. Rehm J, Baliunas D, Borges GLG, Graham K, Irving HM, Kehoe T, Parry CD, Patra J, Popova L, Poznyak V, Roerecke M, Room R, Samokhvalov AV, Taylor B. The relation between different dimensions of alcohol consumption and burden of disease - An overview. Addiction 2010, 105:817-843. 10.1111/j.1360-0443.2010.02899.x, 20331573.
4. Parry CDH, Rehm JR, Poznyak V, Room R. Alcohol and infectious diseases: are there causal linkages?. Addiction 2009, 104:331-332. 10.1111/j.1360-0443.2008.02500.x, 19207335.
5. Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health 2010, 55:159-166. 10.1007/s00038-009-0095-x, 19949966.
6. Shuper PA, Neuman M, Kanteres F, Baliunas D, Joharchi N, Rehm J. Causal considerations on alcohol and HIV/AIDS - a systematic review. Alcohol Alcohol 2010, 45:159-166.
7. World Health Organization The global burden of disease: 2004 update 2008, Geneva, Switzerland, World Health Organization.
8. Havlir DV, Richman DD. Viral dynamics of HIV: implications for drug development and therapeutic strategies. Annals of internal medicine 1996, 124:984-994.
9. Palella FJ, Deloria-Knoll M, Chmiel JS. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Annals of internal medicine 2003, 138:620-626.
10. Jensen-Fangel S, Pedersen L, Pedersen C. Low mortality in HIV-infected patients starting highly active antiretroviral therapy: a comparison with the general population. AIDS 2004, 18:89-97. 10.1097/00002030-200401020-00011, 15090834.
11. Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, Montaner JS. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. Journal of Acquired Immune Deficiency Syndromes 2009, 50:529-536. 10.1097/QAI.0b013e31819675e9, 19223785.
12. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G. Adherence to Highly Active Antiretroviral Therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 2006, 43:78-84. 10.1097/01.qai.0000225015.43266.46, 16878045.
13. Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough?. Journal of general internal medicine 2002, 17:812-813. 10.1046/j.1525-1497.2002.20812.x, 1495121, 12390559.
14. Paterson DL, Swindells S, Mohr J. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of internal medicine 2000, 133:21-30.
15. Fielden SJ, Rusch MLA, Yip B, Wood E, Shannon K, Levy AR, Muntaner JSG, Hogg RS. Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naive patients started on HAART. Journal of the International Association of Physicians in AIDS Care: JIAPAC 2008, 7:238-244.
16. Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients. Journal of Acquired Immune Deficiency Syndromes 2002, 30:105-110. 10.1097/00126334-200205010-00014, 12048370.
17. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine 2006, 11:438.
18. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol Use and Antiretroviral Adherence: Review and Meta-Analysis. Journal of Acquired Immune Deficiency Syndromes 2009, 52:180-202. 10.1097/QAI.0b013e3181b18b6e, 2815237, 19668086.
19. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology 2008, Lippincott, Williams, & Wilkins.
20. Fritz K, Morojele N, Kalichman S. Alcohol: the forgotten drug in HIV/AIDS. Lancet 2010, 376:398-400. 10.1016/S0140-6736(10)60884-7, 3015091, 20650516.
21. UNAIDS 2006 Report on the global AIDS epidemic 2006, Geneva, Switzerland, UNAIDS.
22. Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JSG. Differential impact of adherence on long-term treatment response among naïve HIV-infected individuals. AIDS 2008, 22:2371-2380. 10.1097/QAD.0b013e328315cdd3, 18981777.
23. Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ. Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease. Annals of internal medicine 2001, 135:17-26.
24. Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology 1999, 10:594-605. 10.1097/00001648-199909000-00029, 10468439.
25. Ezzati M, Lopez AD, Rodgers A, Murray CJL. Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors 2004, Geneva: World Health Organization.
26. Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics 1976, 32:829-849. 10.2307/2529268, 1009228.
27. Walter SD. Prevention of multifactorial disease. Am J Epidemiol 1980, 112:409-416.
28. Kalos MH, Whitlock PA. Monte Carlo Methods 2008, Weinheim, Germany: WILEY-VCH.
29. Gmel G, Shield K, Frick H, Kehoe T, Gmel G, Rehm J. Estimating uncertainty for alcohol-attributable fractions for infectious and chronic diseases. BMC Medical Research Methodology 2010,
30. Gmel G, Kuntsche E, Rehm J. Risky single occasion drinking: bingeing is not bingeing. Addiction 2010,
31. Rehm J, Klotsche J, Patra J. Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 2007, 16:66-76. 10.1002/mpr.204, 17623386.
32. Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G. Statistical modelling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr 2010, 8:3. 10.1186/1478-7954-8-3, 2841092, 20202213.
33. Marcellin F, Boyer S, Potopopescu C, Dia A, Ongolo-Zogo P, Koulla-Shiro S, Abega SC, Abe C, Moatti JP, Spire B, Carrieri MP. Determinants of unplanned antiretroviral treatment interruptions among people living with HIV in Yaoundé, Cameroon. Tropical medicine & international health 2008, 13:1470-1478.
34. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, Graham K, Grube J, Gruenewald P, Hill L, Holder H, Homel R, Livingston M, Österberg E, Rehm J, Room R, Rossow I. Alcohol: No ordinary commodity. Research and public policy 2010, Oxford and London: Oxford University Press, 2.